1. Home
  2. XLO vs STSS Comparison

XLO vs STSS Comparison

Compare XLO & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$7.79

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.85

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
STSS
Founded
2016
2017
Country
United States
United States
Employees
N/A
55
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
43.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XLO
STSS
Price
$7.79
$1.85
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
29.0K
183.2K
Earning Date
05-14-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$1.42
52 Week High
$9.25
$18.23

Technical Indicators

Market Signals
Indicator
XLO
STSS
Relative Strength Index (RSI) 42.24 48.87
Support Level $7.40 $1.66
Resistance Level $8.97 $2.00
Average True Range (ATR) 0.40 0.11
MACD -0.11 -0.02
Stochastic Oscillator 13.11 25.00

Price Performance

Historical Comparison
XLO
STSS

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

Share on Social Networks: